Effects of cyclosporine on bone mineral density in patients with glucocorticoid-dependent nephrotic syndrome in remission

@article{Shimizu2012EffectsOC,
  title={Effects of cyclosporine on bone mineral density in patients with glucocorticoid-dependent nephrotic syndrome in remission},
  author={Chie Shimizu and Takayuki Fujita and Yoshinobu Fuke and Minako Yabuki and Mamiko Kajiwara and Seiichiro Hemmi and Atsushi Satomura and Masayoshi Soma},
  journal={International Urology and Nephrology},
  year={2012},
  volume={45},
  pages={803-808}
}
Cyclosporine (CsA) is often prescribed to patients with glucocorticoid (GC)-dependent nephrotic syndrome. Although it is well known that long-term administration of GC causes osteoporosis, the effects of CsA on bone metabolism are not fully established. Therefore, we examined the effects of CsA on bone metabolism in patients with GC-dependent nephrotic syndrome in remission. We followed 23 patients treated with prednisolone alone (GC alone group) and 17 patients treated with CsA in combination… CONTINUE READING
BETA

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Useful therapy of cyclosporine A for adult steroid-dependent nephrotic syndrome

  • K Ito, T Fujita, A Satomura, K Matsumoto
  • J Nihon Univ Med Ass 65:326–332
  • 2006
2 Excerpts

Similar Papers

Loading similar papers…